The crew at Yala is presently conducting a randomized clinical study to assess the effectiveness of its breast cancer forecasting model, Mirai, in enhancing patient results.

The article UC Berkeley professor Adam Yala is at the forefront of AI for cancer forecasting first appeared on Berkeley News.